NewsRx

Search our medical news database

Advaxis, Inc.

Advaxis Scientific Founder Published in Prestigious Peer-Reviewed Journal of Immunology

Published in Vaccine Weekly, May 27th, 2009

Dr. Yvonne Paterson (University of Pennsylvania), scientific founder of Advaxis, Inc. (OTCBB: ADXS) and members of her laboratory have a recently published work in the peer-reviewed Journal of Immunology on a new anti-angiogenic cancer vaccine (Seavey et al . J.I., 2009. 182:5537-46). This agent uses Advaxis proprietary technology to deliver the antigen VEGF-2 (aka fetal liver kinase-1) fused to a non-hemolytic form of the bacterial adjuvant Listeriolysin-O via a bioengineered strain of living Listeria monocytogenes.

As reported in the paper, “Lm-Listeriolysin-O-fetal liver kinase-1 was able to eradicate some established breast tumors, reduce micro-vascular density in...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook